You have 9 free searches left this month | for more free features.

Radiolabeling

Showing 1 - 25 of 28

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Trial in Cincinnati, Seattle (INTERCEPT Treated Platelets)

Completed
  • Healthy
  • INTERCEPT Treated Platelets
  • Cincinnati, Ohio
  • +1 more
Aug 30, 2021

Solid Tumor, Lung Cancer Trial in Beijing (18F-WL12 PET or 68Ga-WL12 PET)

Recruiting
  • Solid Tumor
  • Lung Cancer
  • 18F-WL12 PET or 68Ga-WL12 PET
  • Beijing, China
    Shunlian Zhou
Jul 18, 2022

PSMA-PET Imaging of Salivary Gland Tumours and Other Rare

Recruiting
  • Salivary Gland Tumor
  • Rare Malignant Neoplasm
  • 68-Ga PSMA PET scan
  • Singapore, Singapore
    National Cancer Centre Singapore
Oct 11, 2022

Prostate Cancer Trial ([99mTc]Tc-PSMA-T4)

Not yet recruiting
  • Prostate Cancer
  • [99mTc]Tc-PSMA-T4
  • (no location specified)
Apr 26, 2023

Hemorrhage, Platelets; Defect, Bleeding Trial in Seattle (Cold stored platelets in 100% plasma stored for 10-14 days, Room

Not yet recruiting
  • Hemorrhage
  • +3 more
  • Cold stored platelets in 100% plasma stored for 10-14 days
  • Room temperature stored platelets in 100% plasma stored for up to 7 days
  • Seattle, Washington
    Swedish Medical Center - Cherry Hill
Jan 21, 2022

Prostate Cancer Trial in Sapporo city, Kanazawa-city (177Lu-PSMA-617, 68Ga-PSMA-11, Best supportive/best standard of care)

Recruiting
  • Prostate Cancer
  • 177Lu-PSMA-617
  • +2 more
  • Kashiwa, Chiba, Japan
  • +6 more
Jan 23, 2023

Rheumatoid Arthritis Trial in United States (TC99m-tilmanocept)

Completed
  • Rheumatoid Arthritis
  • Scottsdale, Arizona
  • +9 more
Aug 11, 2021

Diabetic Kidney Disease Trial in San Diego (Tc-99m-Tilmanocept)

Recruiting
  • Diabetic Kidney Disease
  • Tc-99m-Tilmanocept
  • San Diego, California
    UC San Diego Medical Center
Feb 16, 2022

Prostate Cancer Trial in New York (huJ591, 89Zr-J591)

Completed
  • Prostate Cancer
  • New York, New York
    Weill Cornell Medical College
Oct 1, 2020

Gestational Diabetes Trial in Nijmegen (68Ga-NODAGA-exendin-4 PET/CT)

Recruiting
  • Gestational Diabetes
  • 68Ga-NODAGA-exendin-4 PET/CT
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Jun 15, 2021

Abbott Vital® asAlternative Meal to Gold-standard Egg-white

Completed
  • Healthy
  • Egg-white sandwich
  • Abbott Vital®
  • Kota Bharu, Malaysia
    Hospital Universiti Sains Malaysia
Apr 6, 2021

Breast Cancer, Doxorubicin Induced Cardiomyopathy Trial in Ottawa (99mTc-rhAnnexin V-128)

Terminated
  • Breast Cancer
  • Doxorubicin Induced Cardiomyopathy
  • 99mTc-rhAnnexin V-128
  • Ottawa, Ontario, Canada
    University of Ottawa Heart Institute
Nov 17, 2020

Endocarditis, Thrombosis Trial in Paris (99mTc-Annexin V-128 SPECT)

Terminated
  • Endocarditis
  • Thrombosis
  • 99mTc-Annexin V-128 SPECT
  • Paris, France
    Bichat Hospital
Aug 25, 2021

Inflammatory Breast Carcinoma Trial in Boston (89Zr-bevacizumab, FDG-PET/CT, MRI scan)

Completed
  • Inflammatory Breast Carcinoma
  • Boston, Massachusetts
  • +1 more
Dec 10, 2019

PET-CT Imaging of Neuro-endocrine Tumors and Preliminary

Completed
  • Neuroendocrine Tumors
  • 68Ga-DOTATOC PET-CT Imaging
  • Bordeaux, France
    CHU de Bordeaux
Aug 3, 2017

Healthy Trial in Cincinnati (Mirasol System for Whole Blood.)

Terminated
  • Healthy
  • Mirasol System for Whole Blood.
  • Cincinnati, Ohio
    University of Cincinnati, Hoxworth Blood Center
Aug 15, 2019

Blood Safety Trial in Bergen (Mirasol treatment of whole blood)

Completed
  • Blood Safety
  • Mirasol treatment of whole blood
  • Bergen, Norway
    Haukeland University Hospital
May 30, 2019

Adult Healthy Volunteers Trial in Chapel Hill (modified Handihaler DPI, standard Handihaler DPI)

Completed
  • Adult Healthy Volunteers
  • modified Handihaler DPI
  • standard Handihaler DPI
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill, CEMALB
Jan 20, 2017

Breast Cancer, Prostate Cancer, Lung Cancer Trial run by the NCI (111Indium CHX-A)

Terminated
  • Breast Cancer
  • +3 more
  • 111Indium CHX-A
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 8, 2019

Thrombocytopenia Trial in Canada, Netherlands, Norway (Pathogen reduced plasma-stored platelet concentrates, Plasma-stored

Completed
  • Thrombocytopenia
  • Pathogen reduced plasma-stored platelet concentrates
  • Plasma-stored platelet concentrates
  • Hamilton, Canada
  • +9 more
Aug 21, 2018

Healthy Trial (INTERCEPT treated platelets)

Completed
  • Healthy
  • INTERCEPT treated platelets
  • (no location specified)
Nov 6, 2017

Healthy Trial in Lebanon, Cincinnati (Autologous apheresis Platelet Components, prepared with the INTERCEPT Blood System for

Terminated
  • Healthy
  • Autologous apheresis Platelet Components, prepared with the INTERCEPT Blood System for Platelets.
  • Autologous apheresis Conventional untreated Platelet Components
  • Lebanon, New Hampshire
  • +1 more
Jan 24, 2018

Red Cell Survival in Healthy Volunteers Trial in Cincinnati (Red cell survival in INTERCEPT treated red cells)

Unknown status
  • Red Cell Survival in Healthy Volunteers
  • Red cell survival in INTERCEPT treated red cells
  • Cincinnati, Ohio
    Hoxworth Blood Center
Jan 7, 2019

Healthy Trial in Seattle (Blood Collection and autologous re-infusion)

Completed
  • Healthy
  • Blood Collection and autologous re-infusion
  • Seattle, Washington
    Puget Sound Blood Center
Aug 3, 2017

HIV Prevention Trial in Baltimore (Rectal formulation (RF) of tenofovir 1% gel, Vaginal formulation (VF) of tenofovir 1% gel,

Completed
  • HIV Prevention
  • Rectal formulation (RF) of tenofovir 1% gel
  • +3 more
  • Baltimore, Maryland
    Johns Hopkins University, Division of Clinical Pharmacology, Dru
May 6, 2014